Inventor

JOHNSON ALAN T

US79 patents

⚠️ This page may combine multiple inventors who share the name “JOHNSON ALAN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JOHNSON ALAN T

ALLERGAN INC

Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity

Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives

Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

Substituted acetylenes having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity

O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity

O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Methods for identifying inhibitors of cytochrome P450RAI

ALLERGAN SALES INC

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activity

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

(unassigned)

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Alkylidene substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

JOHNSON ALAN T

DNA-decorated graphene chemical sensors

Hoist and accumulator arm apparatus

EXELIXIS INC

Isoquinolinone derivatives and their use as therapeutic agents

UNIV PENNSYLVANIA

Tip calibration standard and method for tip calibration

LUO ZHENGTANG

High yield preparation of macroscopic graphene oxide membranes